Involvement In Dermatomyositis Research Articles

P010 Skin involvement in dermatomyositis (DM)

P010 Skin involvement in dermatomyositis (DM)

Scalp involvement in dermatomyositis: often overlooked or misdiagnosed: Kasteler JS, Callen JP. JAMA 1994;272:1939–1941

Scalp involvement in dermatomyositis: often overlooked or misdiagnosed: Kasteler JS, Callen JP. JAMA 1994;272:1939–1941

Scalp Involvement in Dermatomyositis

To characterize scalp involvement in patients with dermatomyositis. Case series. All patients with dermatomyositis seen in our office between 1988 and mid 1993. Patient inclusion in this study required fulfillment of three or more of Bohan and Peter's criteria for dermatomyositis. Of 17 patients with the diagnosis of dermatomyositis, scalp involvement was present in 14. Five of the 14 patients with scalp involvement were diagnosed as having scalp psoriasis or seborrheic dermatitis before progression of their disease or tissue examination revealed the diagnosis of dermatomyositis. In all patients, the scalp involvement was manifested as atrophic, erythematous, scaly plaques. In addition, alopecia was noted in six of the 14 patients. Treatment of cutaneous involvement included sun avoidance, topical corticosteroids and/or antimalarials, and/or methotrexate. Recognition of this process is important because scalp involvement is often overlooked, may be misdiagnosed initially, and can be the presenting complaint in some patients with dermatomyositis.

Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed

Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed

Discordance of Skin and Muscle Involvement in Dermatomyositis

International Journal of DermatologyVolume 24, Issue 1 p. 518-519 Discordance of Skin and Muscle Involvement in Dermatomyositis Elie Gertner M.D., Elie Gertner M.D. Rheumatic Disease Unit, The Wellesley Hospital, Toronto, Ontario, CanadaSearch for more papers by this authorMurray B. Urowitz M.D., Corresponding Author Murray B. Urowitz M.D. Rheumatic Disease Unit, The Wellesley Hospital, Toronto, Ontario, CanadaAddress for correspondence: Murray B. Urowitz M.D., Suite 651 A, The Wellesley Hospital, 160 Wellesley Street East, Toronto, Ontario M4Y 1J3, Canada.Search for more papers by this author Elie Gertner M.D., Elie Gertner M.D. Rheumatic Disease Unit, The Wellesley Hospital, Toronto, Ontario, CanadaSearch for more papers by this authorMurray B. Urowitz M.D., Corresponding Author Murray B. Urowitz M.D. Rheumatic Disease Unit, The Wellesley Hospital, Toronto, Ontario, CanadaAddress for correspondence: Murray B. Urowitz M.D., Suite 651 A, The Wellesley Hospital, 160 Wellesley Street East, Toronto, Ontario M4Y 1J3, Canada.Search for more papers by this author First published: January 1985 https://doi.org/10.1111/j.1365-4362.1985.tb05547.xCitations: 12AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume24, Issue1January 1985Pages 518-519 RelatedInformation

Fatal pulmonary involvement in dermatomyositis.

A 12-year-old boy with classic dermatomyositis developed a rapidly progressive pulmonary process that led to his death a month later. Physiologically, there was interference with the oxygenation of the blood even when 100% oxygen was delivered to the lungs under pressure. Microscopic examination of the lungs disclosed diffuse interstitial pulmonary fibrosis. We conclude that these pulmonary changes were a component of the basic disease.